Overview
Katsumichi Fujimaki practices practicing medicine in Fujisawa, Japan.
Fujimaki is highly rated in 8 conditions, according to our data. Their clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), Chronic Myelogenous Leukemia (CML), Leukemia, Non-Hodgkin Lymphoma, and Bone Marrow Transplant.
They are actively involved in clinical research, co-authoring 79 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Katsumichi Fujimaki
Is Katsumichi Fujimaki a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Katsumichi Fujimaki is classified as an Advanced expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Katsumichi Fujimaki participate in research or clinical trials?
Yes. Katsumichi Fujimaki has published 79 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Katsumichi Fujimaki's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Myeloid Leukemia (AML)Fujimaki isAdvanced. Learn about Acute Myeloid Leukemia (AML).
- Acute Promyelocytic LeukemiaFujimaki isAdvanced. Learn about Acute Promyelocytic Leukemia.
- B-Cell LymphomaFujimaki isAdvanced. Learn about B-Cell Lymphoma.
- Chronic Myelogenous Leukemia (CML)
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Follicular LymphomaFujimaki isAdvanced. Learn about Follicular Lymphoma.
- LeukemiaFujimaki isAdvanced. Learn about Leukemia.
- Non-Hodgkin LymphomaFujimaki isAdvanced. Learn about Non-Hodgkin Lymphoma.
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Fujimaki isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Immune ThrombocytopeniaFujimaki isExperienced. Learn about Adult Immune Thrombocytopenia.
- Blood ClotsFujimaki isExperienced. Learn about Blood Clots.
- Bone Marrow TransplantFujimaki isExperienced. Learn about Bone Marrow Transplant.
- Chronic Myelomonocytic Leukemia (CMML)
- Disseminated Intravascular Coagulation
- Graft Versus Host Disease (GvHD)Fujimaki isExperienced. Learn about Graft Versus Host Disease (GvHD).
- Immune Thrombocytopenic Purpura (ITP)
- Lymphofollicular HyperplasiaFujimaki isExperienced. Learn about Lymphofollicular Hyperplasia.
- Multiple MyelomaFujimaki isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Fujimaki isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- PurpuraFujimaki isExperienced. Learn about Purpura.
- ThrombocytopeniaFujimaki isExperienced. Learn about Thrombocytopenia.
- Wilms TumorFujimaki isExperienced. Learn about Wilms Tumor.